OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
301580$61.1256

Aidite Qinhuangdao Technology Co Ltd

Medical Equipment, Supplies & DistributionVerified

Aidite Qinhuangdao Technology Co Ltd maintains a strong liquidity position, with a current ratio of 8.14, indicating a high ability to meet short-term obligations. The company's price-to-book ratio is 3.05, and its price-to-tangible-book ratio is also 3.05, suggesting that the market values the company's equity at a premium relative to its book value. The debt-to-equity ratio is 0.01, reflecting a conservative capital structure with minimal leverage. In terms of profitability, the company's return on equity (ROE) is 9.18%, and its return on assets (ROA) is 7.97%. These figures are above the industry median for ROE and ROA, indicating that the company is generating strong returns relative to its equity and asset base. The company's operating margin is 20.82% (calculated as operating income of 215,398,150 CNY divided by revenue of 1,034,781,320 CNY), which is also above the industry median for operating margins. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic breakdown provided. This lack of geographic diversification may expose the company to regional economic or regulatory risks. The company's revenue concentration in a single segment suggests that its performance is highly dependent on the success of that particular business line. Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant changes in revenue or earnings expected in the next fiscal year. The company's capital expenditure is negative at -68,781,360 CNY, indicating that it is generating more cash from operations than it is investing in new assets. This suggests a focus on maintaining existing operations rather than expanding into new markets or product lines. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of concern is that the company's net cash is negative after subtracting total debt, which could indicate potential liquidity constraints in the short term. However, the company's strong operating cash flow of 273,658,550 CNY and free cash flow of 118,321,270 CNY provide a buffer against short-term liquidity pressures. The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares. Recent filings and transcripts do not indicate any material events that would significantly impact the company's operations or financial position. The company's financial statements show consistent performance, with no unusual items or one-time charges reported. The company's management has not disclosed any major strategic shifts or new initiatives in recent communications.

30-day price · 301580(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyAidite Qinhuangdao Technology Co Ltd
Ticker301580.SZ
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Aidite Qinhuangdao Technology Co Ltd provides medical equipment, supplies, and distribution services within the healthcare sector.

Classification. The company is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

Aidite Qinhuangdao Technology Co Ltd maintains a strong liquidity position, with a current ratio of 8.14, indicating a high ability to meet short-term obligations. The company's price-to-book ratio is 3.05, and its price-to-tangible-book ratio is also 3.05, suggesting that the market values the company's equity at a premium relative to its book value. The debt-to-equity ratio is 0.01, reflecting a conservative capital structure with minimal leverage. In terms of profitability, the company's return on equity (ROE) is 9.18%, and its return on assets (ROA) is 7.97%. These figures are above the industry median for ROE and ROA, indicating that the company is generating strong returns relative to its equity and asset base. The company's operating margin is 20.82% (calculated as operating income of 215,398,150 CNY divided by revenue of 1,034,781,320 CNY), which is also above the industry median for operating margins. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic breakdown provided. This lack of geographic diversification may expose the company to regional economic or regulatory risks. The company's revenue concentration in a single segment suggests that its performance is highly dependent on the success of that particular business line. Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant changes in revenue or earnings expected in the next fiscal year. The company's capital expenditure is negative at -68,781,360 CNY, indicating that it is generating more cash from operations than it is investing in new assets. This suggests a focus on maintaining existing operations rather than expanding into new markets or product lines. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of concern is that the company's net cash is negative after subtracting total debt, which could indicate potential liquidity constraints in the short term. However, the company's strong operating cash flow of 273,658,550 CNY and free cash flow of 118,321,270 CNY provide a buffer against short-term liquidity pressures. The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares. Recent filings and transcripts do not indicate any material events that would significantly impact the company's operations or financial position. The company's financial statements show consistent performance, with no unusual items or one-time charges reported. The company's management has not disclosed any major strategic shifts or new initiatives in recent communications.
Key takeaways
  • The company has a strong liquidity position with a current ratio of 8.14 and a low debt-to-equity ratio of 0.01.
  • Aidite Qinhuangdao Technology Co Ltd generates strong returns, with a return on equity of 9.18% and a return on assets of 7.97%.
  • The company's revenue is concentrated in a single business segment, which may increase its exposure to sector-specific risks.
  • The company is expected to maintain a stable growth trajectory, with no significant changes in revenue or earnings expected in the next fiscal year.
  • The company's risk profile is characterized by medium liquidity risk and low dilution risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.03B
Gross profit$534.1M
Operating income$215.4M
Net income$196.2M
R&D
SG&A
D&A
SBC
Operating cash flow$273.7M
CapEx-$68.8M
Free cash flow$118.3M
Total assets$2.46B
Total liabilities$326.1M
Total equity$2.14B
Cash & equivalents
Long-term debt$12.7M
Valuation
Market price$61.12
Market cap$6.51B
Enterprise value$6.53B
P/E33.2
Reported non-GAAP P/E
EV/Revenue6.3
EV/Op income30.3
EV/OCF23.9
P/B3.0
P/Tangible book3.0
Tangible book$2.14B
Net cash-$12.7M
Current ratio8.1
Debt/Equity0.0
ROA8.0%
ROE9.2%
Cash conversion1.4%
CapEx/Revenue-6.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric301580Activity
Op margin20.8%13.3% medp25 5.9% · p75 13.5%top quartile
Net margin19.0%8.6% medp25 2.7% · p75 12.7%top quartile
Gross margin51.6%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-6.7%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity1.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-25 06:29 UTCJob: 49528b0d